MedPath

H. Lee Moffitt Cancer Center and Research Institute, Inc.

H. Lee Moffitt Cancer Center and Research Institute, Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer

Phase 1
Completed
Conditions
Squamous Cell Carcinoma
Adenosquamous Carcinoma
Advanced NSCLC
Adenocarcinomas
Metastatic Non-small Cell Lung Cancer
Non-Small Cell Lung Cancer
Interventions
Procedure: Tumor-infiltrating Lymphocytes (TIL)
Other: Tumor-infiltrating Lymphocyte Therapy
First Posted Date
2017-07-12
Last Posted Date
2023-07-24
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
20
Registration Number
NCT03215810
Locations
🇺🇸

University of Florida Health Cancer Center., Gainesville, Florida, United States

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC

Phase 1
Completed
Conditions
Metastatic Lung Cancer
Non Small Cell Lung Cancer
Advanced Cancer
Squamous Cell Lung Cancer
Non-Squamous Non-Small Cell Neoplasm of Lung
Lung Cancer
Interventions
First Posted Date
2017-06-06
Last Posted Date
2025-05-20
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
48
Registration Number
NCT03177291
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population

Not Applicable
Completed
Conditions
Cancer
Interventions
Behavioral: Patient Navigator (PN)
Other: Baseline Questionnaire
Other: Follow-up Questionnaire
Other: Patient Navigator Satisfaction Survey
First Posted Date
2017-06-05
Last Posted Date
2021-09-14
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
28
Registration Number
NCT03176576
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer

Not Applicable
Terminated
Conditions
Breast Cancer Female
Breast Adenocarcinoma
Breast Cancer
Interventions
Procedure: Breast-conserving Surgery
First Posted Date
2017-05-03
Last Posted Date
2023-02-23
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
20
Registration Number
NCT03137693
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Breast Cancer Female
HER2-positive Breast Cancer
Breast Cancer, Male
Interventions
Biological: Interferon-gamma (IFN-γ)
Other: Pertuzumab
Procedure: Post Therapy Surgery
First Posted Date
2017-04-13
Last Posted Date
2023-04-19
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
51
Registration Number
NCT03112590
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks

Not Applicable
Completed
Conditions
Colorectal Cancer
Colorectal Carcinoma
Interventions
Other: Fecal Immunochemical Test (FIT) Kit
Behavioral: Screen for Life Brochure
Behavioral: Culturally targeted Photo Novella Booklet
First Posted Date
2017-03-13
Last Posted Date
2022-11-09
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
331
Registration Number
NCT03078348
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening)

Not Applicable
Completed
Conditions
Colorectal Cancer
Colorectal Carcinoma
Interventions
Other: Immunochemical Fecal Occult Blood Test (I-FOBT) Kit
Behavioral: LATINOS CARES Toolkit
Behavioral: Standard Intervention
First Posted Date
2017-03-13
Last Posted Date
2023-01-11
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
159
Registration Number
NCT03078361
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Pilot Study of Regional Lung Ventilation

Not Applicable
Completed
Conditions
Non-small Cell Lung Cancer
Interventions
Diagnostic Test: 4-D CT Scan
Diagnostic Test: SPECT-CT Scan
First Posted Date
2017-03-10
Last Posted Date
2017-03-13
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
3
Registration Number
NCT03077113
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Other: Fleet Enema
Device: Aixplorer® ShearWave Elastography (SWE™)
Diagnostic Test: Pre-surgery Ultrasound
Procedure: Prostatectomy
First Posted Date
2017-03-10
Last Posted Date
2017-03-13
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
10
Registration Number
NCT03077126
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms

Phase 1
Completed
Conditions
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Myeloproliferative Neoplasm
Chronic Myelomonocytic Leukemia
Interventions
First Posted Date
2017-03-07
Last Posted Date
2022-01-24
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
55
Registration Number
NCT03072043
Locations
🇺🇸

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

🇺🇸

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath